The Use of Prophylactic Antibiotics In the Management of Dog Bites
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in
the management of uncomplicated dog bites, utilizing currently best available antibiotics
(Augmentin) and an important clinical outcome of infection.
By enrolling 100-150 patients in this pilot trial as part of a k-award the investigators plan
to utilize the point estimates of infection, side effects and other important outcomes and
incorporate these into a cost most to determine the most cost effective management of these
wounds and to determine if further study is warranted based on the findings.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Stanford University
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)